5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR) Peptide
Quick Overview for 5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR) Peptide (ABIN938943)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- GSEQLDVADL RRLRYKGIRP APGYPSQPDH TEKLTMWRLA DIEQSTGIRL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MTR antibody,
Alternative Names: MTR control peptide, MTR antibody Blocking Peptide, Anti-MTR Blocking Peptide, 5-Methyltetrahydrofolate-Homocysteine Methyltransferase Blocking Peptide, FLJ45386 Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- MTR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR))
-
Background
- MTR is the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G.
-
Molecular Weight
- 140 kDa
Target
-